In patients with transthyretin amyloid cardiomyopathy, the high-affinity TTR stabilizer, acoramidis, is associated with better clinical outcomes compared with placebo. Acoramidis is associated with ...

Even as Biogen and Eisai’s Leqembi and Eli Lilly’s Kisunla slowly roll out onto the market, experts question the efficacy of these anti-amyloid antibodies and the amyloid hypothesis overall. Despite ...

Attruby (acoramidis) Transthyretin stabilizer For the treatment of the cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis in adults to reduce cardiovascular death and ...